Asymptomatic Plasmodium vivax parasitaemia in the low-transmission setting: the role for a population-based transmission-blocking vaccine for malaria elimination

Plasmodium vivax remains an important cause of morbidity and mortality across the Americas, Horn of Africa, East and South East Asia. Control of transmission has been hampered by emergence of chloroquine resistance and several intrinsic characteristics of infection including asymptomatic carriage, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Thomas C. S., Vinetz, Joseph M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822557/
https://www.ncbi.nlm.nih.gov/pubmed/29466991
http://dx.doi.org/10.1186/s12936-018-2243-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822557/
https://www.ncbi.nlm.nih.gov/pubmed/29466991
http://dx.doi.org/10.1186/s12936-018-2243-3

Ejemplares similares